1,2-dimethylhydrazine multiple interactions ISO Atp6v1d (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6V1D mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ATP6V1D mRNA CTD PMID:25380136 1-nitropropane increases expression EXP 6480464 1-nitropropane results in increased expression of ATP6V1D mRNA CTD PMID:17070881 17alpha-ethynylestradiol increases expression ISO Atp6v1d (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of ATP6V1D mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO Atp6v1d (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP6V1D mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO Atp6v1d (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of ATP6V1D mRNA CTD PMID:17555576 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO ATP6V1D (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Atp6v1d (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP6V1D mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Atp6v1d (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ATP6V1D mRNA CTD PMID:21570461 2,4-diaminotoluene increases expression EXP 6480464 2 and 4-diaminotoluene results in increased expression of ATP6V1D mRNA CTD PMID:17070881 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of ATP6V1D mRNA CTD PMID:21346803 2,6-diaminotoluene increases expression EXP 6480464 2 and 6-diaminotoluene results in increased expression of ATP6V1D mRNA CTD PMID:17070881 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of ATP6V1D mRNA CTD PMID:21346803 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of ATP6V1D mRNA CTD PMID:17070881 2-hydroxypropanoic acid decreases expression ISO ATP6V1D (Homo sapiens) 6480464 Lactic Acid results in decreased expression of ATP6V1D mRNA CTD PMID:30851411 2-methylcholine affects expression ISO ATP6V1D (Homo sapiens) 6480464 beta-methylcholine affects the expression of ATP6V1D mRNA CTD PMID:21179406 2-nitro-p-phenylenediamine increases expression EXP 6480464 2-nitro-4-phenylenediamine results in increased expression of ATP6V1D mRNA CTD PMID:17070881 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of ATP6V1D mRNA CTD PMID:14600272 more ... 2-nitropropane increases expression EXP 6480464 2-nitropropane results in increased expression of ATP6V1D mRNA CTD PMID:17070881 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of ATP6V1D mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of ATP6V1D mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ATP6V1D mRNA CTD PMID:36041667 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ATP6V1D mRNA CTD PMID:14600272 more ... 4-acetylaminofluorene increases expression EXP 6480464 4-acetylaminofluorene results in increased expression of ATP6V1D mRNA CTD PMID:17070881 4-nitro-1,2-phenylenediamine increases expression EXP 6480464 1 and 2-diamino-4-nitrobenzene results in increased expression of ATP6V1D mRNA CTD PMID:17070881 acrolein multiple interactions ISO ATP6V1D (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6V1D mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP6V1D mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ATP6V1D mRNA CTD PMID:28959563 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ATP6V1D mRNA CTD PMID:14600272 more ... aflatoxin B1 decreases methylation ISO ATP6V1D (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of ATP6V1D gene CTD PMID:27153756 aflatoxin B1 increases expression ISO ATP6V1D (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of ATP6V1D mRNA CTD PMID:27153756 alpha-pinene multiple interactions ISO ATP6V1D (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6V1D mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP6V1D mRNA CTD PMID:32699268 anthracen-2-amine increases expression EXP 6480464 2-anthramine results in increased expression of ATP6V1D mRNA CTD PMID:23038007 Aroclor 1254 decreases expression ISO Atp6v1d (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ATP6V1D mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO ATP6V1D (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to ATP6V1D mRNA] CTD PMID:32406909 benzo[a]pyrene increases expression ISO Atp6v1d (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ATP6V1D mRNA CTD PMID:21715664 bisphenol A decreases expression ISO ATP6V1D (Homo sapiens) 6480464 bisphenol A results in decreased expression of ATP6V1D mRNA and bisphenol A results in decreased expression of ATP6V1D protein CTD PMID:29275510 and PMID:33376534 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ATP6V1D mRNA CTD PMID:36041667 bisphenol A decreases expression ISO Atp6v1d (Mus musculus) 6480464 bisphenol A results in decreased expression of ATP6V1D mRNA CTD PMID:33221593 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATP6V1D mRNA CTD PMID:25181051 and PMID:32145629 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ATP6V1D mRNA CTD PMID:36041667 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of ATP6V1D protein CTD PMID:28903499 cadmium dichloride increases expression ISO Atp6v1d (Mus musculus) 6480464 Cadmium Chloride results in increased expression of ATP6V1D mRNA CTD PMID:30030080 caffeine decreases phosphorylation ISO ATP6V1D (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of ATP6V1D protein CTD PMID:35688186 captan increases expression ISO Atp6v1d (Mus musculus) 6480464 Captan results in increased expression of ATP6V1D mRNA CTD PMID:31558096 chloropicrin affects expression ISO ATP6V1D (Homo sapiens) 6480464 chloropicrin affects the expression of ATP6V1D mRNA CTD PMID:26352163 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP6V1D mRNA CTD PMID:17602206 cocaine affects expression EXP 6480464 Cocaine affects the expression of ATP6V1D mRNA CTD PMID:20187946 copper(II) sulfate increases expression ISO ATP6V1D (Homo sapiens) 6480464 Copper Sulfate results in increased expression of ATP6V1D mRNA CTD PMID:19549813 CU-O LINKAGE increases expression ISO ATP6V1D (Homo sapiens) 6480464 cupric oxide results in increased expression of ATP6V1D mRNA CTD PMID:22077320 cyclosporin A increases expression ISO ATP6V1D (Homo sapiens) 6480464 Cyclosporine results in increased expression of ATP6V1D mRNA CTD PMID:25562108 deoxynivalenol decreases expression ISO ATP6V1D (Homo sapiens) 6480464 deoxynivalenol results in decreased expression of ATP6V1D protein CTD PMID:33890134 dicrotophos decreases expression ISO ATP6V1D (Homo sapiens) 6480464 dicrotophos results in decreased expression of ATP6V1D mRNA CTD PMID:28302478 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of ATP6V1D mRNA CTD PMID:37077353 doxorubicin increases expression ISO ATP6V1D (Homo sapiens) 6480464 Doxorubicin results in increased expression of ATP6V1D mRNA CTD PMID:29803840 epoxiconazole decreases expression ISO Atp6v1d (Mus musculus) 6480464 epoxiconazole results in decreased expression of ATP6V1D mRNA CTD PMID:35436446 ethanol increases expression ISO Atp6v1d (Mus musculus) 6480464 Ethanol results in increased expression of ATP6V1D mRNA CTD PMID:30319688 ethanol multiple interactions ISO Atp6v1d (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of ATP6V1D mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO ATP6V1D (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of ATP6V1D mRNA CTD PMID:23649840 finasteride increases expression EXP 6480464 Finasteride results in increased expression of ATP6V1D mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ATP6V1D mRNA CTD PMID:24136188 folic acid multiple interactions ISO Atp6v1d (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6V1D mRNA CTD PMID:22206623 folic acid decreases expression ISO Atp6v1d (Mus musculus) 6480464 Folic Acid results in decreased expression of ATP6V1D mRNA CTD PMID:25629700 folpet increases expression ISO Atp6v1d (Mus musculus) 6480464 folpet results in increased expression of ATP6V1D mRNA CTD PMID:31558096 furan increases expression EXP 6480464 furan results in increased expression of ATP6V1D mRNA CTD PMID:26194646 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ATP6V1D mRNA CTD PMID:33387578 Heliotrine increases expression EXP 6480464 heliotrine results in increased expression of ATP6V1D mRNA CTD PMID:32419051 hydrazine increases expression EXP 6480464 hydrazine results in increased expression of ATP6V1D mRNA CTD PMID:15370871 hydrogen peroxide affects expression ISO ATP6V1D (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of ATP6V1D mRNA CTD PMID:20044591 isotretinoin decreases expression ISO ATP6V1D (Homo sapiens) 6480464 Isotretinoin results in decreased expression of ATP6V1D mRNA CTD PMID:20436886 ivermectin decreases expression ISO ATP6V1D (Homo sapiens) 6480464 Ivermectin results in decreased expression of ATP6V1D protein CTD PMID:32959892 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of ATP6V1D mRNA CTD PMID:37077353 methidathion increases expression ISO Atp6v1d (Mus musculus) 6480464 methidathion results in increased expression of ATP6V1D mRNA CTD PMID:34813904 methyl methanesulfonate increases expression ISO ATP6V1D (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of ATP6V1D mRNA CTD PMID:23649840 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP6V1D mRNA CTD PMID:17602206 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ATP6V1D mRNA CTD PMID:14600272 and PMID:25380136 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of ATP6V1D mRNA CTD PMID:19716841 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of ATP6V1D mRNA CTD PMID:24136188 ozone multiple interactions ISO ATP6V1D (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6V1D mRNA more ... CTD PMID:32699268 paracetamol increases expression ISO ATP6V1D (Homo sapiens) 6480464 Acetaminophen results in increased expression of ATP6V1D mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ATP6V1D mRNA CTD PMID:33387578 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ATP6V1D mRNA CTD PMID:19162173 picoxystrobin increases expression ISO ATP6V1D (Homo sapiens) 6480464 picoxystrobin results in increased expression of ATP6V1D mRNA CTD PMID:33512557 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ATP6V1D mRNA CTD PMID:19162173 piroxicam decreases expression ISO ATP6V1D (Homo sapiens) 6480464 Piroxicam results in decreased expression of ATP6V1D mRNA CTD PMID:21858171 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of ATP6V1D mRNA CTD PMID:19162173 rac-lactic acid decreases expression ISO ATP6V1D (Homo sapiens) 6480464 Lactic Acid results in decreased expression of ATP6V1D mRNA CTD PMID:30851411 resveratrol multiple interactions ISO ATP6V1D (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP6V1D mRNA CTD PMID:23557933 rotenone increases expression ISO ATP6V1D (Homo sapiens) 6480464 Rotenone results in increased expression of ATP6V1D mRNA CTD PMID:31648047 silicon dioxide increases expression ISO Atp6v1d (Mus musculus) 6480464 Silicon Dioxide results in increased expression of ATP6V1D mRNA CTD PMID:29203145 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of ATP6V1D mRNA CTD PMID:25993096 sodium dichromate increases expression ISO Atp6v1d (Mus musculus) 6480464 sodium bichromate results in increased expression of ATP6V1D mRNA CTD PMID:31558096 Soman decreases expression EXP 6480464 Soman results in decreased expression of ATP6V1D mRNA CTD PMID:19281266 tamoxifen affects expression ISO Atp6v1d (Mus musculus) 6480464 Tamoxifen affects the expression of ATP6V1D mRNA CTD PMID:17555576 temozolomide decreases expression ISO ATP6V1D (Homo sapiens) 6480464 Temozolomide results in decreased expression of ATP6V1D mRNA CTD PMID:31758290 thimerosal increases expression ISO ATP6V1D (Homo sapiens) 6480464 Thimerosal results in increased expression of ATP6V1D mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ATP6V1D mRNA CTD PMID:23411599 and PMID:34492290 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ATP6V1D mRNA CTD PMID:33387578 trichostatin A affects expression ISO ATP6V1D (Homo sapiens) 6480464 trichostatin A affects the expression of ATP6V1D mRNA CTD PMID:28542535 tunicamycin decreases expression ISO ATP6V1D (Homo sapiens) 6480464 Tunicamycin results in decreased expression of ATP6V1D mRNA CTD PMID:29453283 urethane increases expression ISO ATP6V1D (Homo sapiens) 6480464 Urethane results in increased expression of ATP6V1D mRNA CTD PMID:28818685 valproic acid increases expression ISO Atp6v1d (Mus musculus) 6480464 Valproic Acid results in increased expression of ATP6V1D mRNA CTD PMID:20546886 valproic acid increases expression ISO ATP6V1D (Homo sapiens) 6480464 Valproic Acid results in increased expression of ATP6V1D mRNA CTD PMID:23179753 and PMID:29154799 valproic acid affects expression ISO ATP6V1D (Homo sapiens) 6480464 Valproic Acid affects the expression of ATP6V1D mRNA CTD PMID:25979313 vorinostat increases expression ISO ATP6V1D (Homo sapiens) 6480464 vorinostat results in increased expression of ATP6V1D mRNA CTD PMID:27188386